AbCellera Biologics Inc. financial data

Symbol
ABCL on Nasdaq
Industry
Pharmaceutical Preparations
Location
2215 Yukon Street, Vancouver, British Columbia, Canada
State of incorporation
British Columbia, Canada
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2024 - Nov 4, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 856 % -1.96%
Debt-to-equity 28.7 % +9.19%
Return On Equity -15.7 % -46.7%
Return On Assets -12.2 % -44%
Operating Margin -935 % -125%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 295M shares +1.79%
Common Stock, Shares, Outstanding 291M shares +1.39%
Entity Public Float 1.46B USD -99.9%
Common Stock, Value, Issued 773M USD +3.33%
Weighted Average Number of Shares Outstanding, Basic 295M shares +1.85%
Weighted Average Number of Shares Outstanding, Diluted 295M shares +1.85%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 33M USD -34.6%
Research and Development Expense 170M USD +9.35%
Selling and Marketing Expense 12.7M USD -7.52%
General and Administrative Expense 72.7M USD +25.2%
Operating Income (Loss) -308M USD -47.4%
Nonoperating Income (Expense) 106M USD +103%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -202M USD -28.9%
Income Tax Expense (Benefit) -26.4M USD +4.8%
Net Income (Loss) Attributable to Parent -176M USD -36.1%
Earnings Per Share, Basic -0.6 USD/shares -33.3%
Earnings Per Share, Diluted -0.6 USD/shares -33.3%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 127M USD -26.6%
Cash, Cash Equivalents, and Short-term Investments 643M USD
Other Assets, Current 43.4M USD -39.1%
Assets, Current 743M USD -19.2%
Property, Plant and Equipment, Net 277M USD +38.2%
Operating Lease, Right-of-Use Asset 68.3M USD
Intangible Assets, Net (Excluding Goodwill) 52.6M USD -57.6%
Goodwill 47.8M USD 0%
Other Assets, Noncurrent 134M USD +66.3%
Assets 1.39B USD -7.89%
Employee-related Liabilities, Current 5.99M USD -5.65%
Accrued Liabilities, Current 0 USD
Contract with Customer, Liability, Current 5.58M USD -68.1%
Liabilities, Current 79.6M USD -27.8%
Contract with Customer, Liability, Noncurrent 8.1M USD -50.6%
Deferred Income Tax Liabilities, Net 12.8M USD -61.5%
Operating Lease, Liability, Noncurrent 66.3M USD -11.9%
Other Liabilities, Noncurrent 1.52M USD -69.8%
Liabilities 315M USD -4.46%
Accumulated Other Comprehensive Income (Loss), Net of Tax -1.23M USD +15.6%
Retained Earnings (Accumulated Deficit) 151M USD -53.8%
Stockholders' Equity Attributable to Parent 1.08B USD -8.85%
Liabilities and Equity 1.39B USD -7.89%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -41.7M USD +5.35%
Net Cash Provided by (Used in) Financing Activities 2.83M USD
Net Cash Provided by (Used in) Investing Activities 29.9M USD
Common Stock, Shares, Issued 291M shares +1.39%
Common Stock, Par or Stated Value Per Share 0 USD/shares
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -9.75M USD +95%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 152M USD -23.2%
Deferred Tax Assets, Valuation Allowance 33.8M USD +152%
Deferred Tax Assets, Gross 81.2M USD +71.1%
Operating Lease, Liability 77.4M USD -5.93%
Depreciation 14.2M USD +20.8%
Payments to Acquire Property, Plant, and Equipment 24.1M USD +61.1%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -176M USD -35.2%
Property, Plant and Equipment, Gross 304M USD +40.6%
Operating Lease, Liability, Current 5.13M USD -8.02%
Lessee, Operating Lease, Liability, to be Paid, Year Two 9.69M USD +4.89%
Lessee, Operating Lease, Liability, to be Paid, Year One 9.81M USD +2.05%
Operating Lease, Weighted Average Discount Rate, Percent 0.05 pure 0%
Lessee, Operating Lease, Liability, to be Paid, Year Three 9.28M USD +1.62%
Deferred Tax Assets, Operating Loss Carryforwards 7.26M USD +43.6%
Lessee, Operating Lease, Liability, to be Paid, Year Four 8.25M USD -7.03%
Amortization of Intangible Assets 1.69M USD -36.4%
Deferred Tax Assets, Net of Valuation Allowance 34.1M USD +56.9%
Share-based Payment Arrangement, Expense 68.8M USD +12.7%